TipRanks
NervGen Pharma (DE:9UA)
FRANKFURT:9UA
Germany Market

NervGen Pharma (9UA) Balance Sheet

3 Followers

NervGen Pharma Balance Sheet

NervGen Pharma's total assets for Q2 2026 were C$90.34M, an increase of 289.23% from the previous quarter. DE:9UA total liabilities were C$73.03M for the fiscal quarter, a 270.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 26Mar 25Mar 24Dec 22Dec 21
Total Assets
C$ 23.21MC$ 19.47MC$ 13.24MC$ 23.67MC$ 18.03M
Total Liabilities
C$ 19.73MC$ 16.90MC$ 15.25MC$ 10.32MC$ 1.09M
Total Equity Gross Minority
C$ 3.48MC$ 2.57MC$ -2.01MC$ 13.34MC$ 16.95M
Other Metrics
Currency in CAD

NervGen Pharma Debt to Assets